Dolby Laboratories (NYSE:DLB) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Dolby Laboratories (NYSE:DLB) have earned a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $90.75.

A number of equities analysts recently commented on DLB shares. Barrington Research reiterated an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, April 27th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Finally, Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th.

Dolby Laboratories Stock Down 0.1%

NYSE:DLB opened at $53.70 on Monday. The company has a fifty day simple moving average of $58.97 and a two-hundred day simple moving average of $62.62. The company has a market cap of $5.08 billion, a price-to-earnings ratio of 21.23 and a beta of 0.81. Dolby Laboratories has a 52 week low of $52.45 and a 52 week high of $77.00.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, topping the consensus estimate of $1.31 by $0.06. The business had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The company’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, analysts expect that Dolby Laboratories will post 3.21 EPS for the current year.

Dolby Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were issued a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a yield of 2.7%. Dolby Laboratories’s dividend payout ratio (DPR) is 56.92%.

Insider Buying and Selling at Dolby Laboratories

In related news, SVP John D. Couling sold 7,666 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $55.62, for a total transaction of $426,382.92. Following the sale, the senior vice president owned 118,727 shares in the company, valued at approximately $6,603,595.74. This trade represents a 6.07% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Robert J. Park sold 4,895 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total transaction of $277,448.60. Following the sale, the chief financial officer owned 81,490 shares in the company, valued at approximately $4,618,853.20. This trade represents a 5.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 39,791 shares of company stock valued at $2,231,653. Company insiders own 37.93% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. Norges Bank purchased a new stake in Dolby Laboratories during the 4th quarter worth $54,966,000. AQR Capital Management LLC increased its stake in Dolby Laboratories by 51.8% during the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after buying an additional 592,282 shares during the period. First Trust Advisors LP increased its stake in Dolby Laboratories by 19.9% during the 1st quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock worth $135,431,000 after buying an additional 374,405 shares during the period. Alyeska Investment Group L.P. bought a new stake in shares of Dolby Laboratories in the 4th quarter worth about $23,477,000. Finally, Voloridge Investment Management LLC increased its position in shares of Dolby Laboratories by 2,017.9% in the 4th quarter. Voloridge Investment Management LLC now owns 325,499 shares of the electronics maker’s stock worth $20,904,000 after purchasing an additional 310,130 shares during the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.